New Drugs for Treating Dyslipidemia: Beyond Statins
Author:
Affiliation:
1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Publisher
Korean Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism
Link
https://synapse.koreamed.org/pdf/10.4093/dmj.2015.39.2.87
Reference42 articles.
1. Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010
2. Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
3. How to control residual cardiovascular risk despite statin treatment: Focusing on HDL–cholesterol
4. Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
5. Diagnosis and treatment of familial hypercholesterolaemia
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes;Cardiovascular Drugs and Therapy;2024-06-22
2. Role of PCSK9 inhibitors in the management of dyslipidaemia;Indian Heart Journal;2024-03
3. UHPLC Specific Method for Simultaneous Determination of Probable Impurities of Ezetimibeand Simvastatin in Combined Dosage Form;Oriental Journal Of Chemistry;2024-02-25
4. Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?;Cardiology and Therapy;2024-02-21
5. Riesgo residual. Conclusiones;Revista Española de Cardiología Suplementos;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3